Therapeutic Delivery – Products
Whitepaper
Unlocking More Lipid Nanoparticle Insights
Developing mRNA-based therapeutics is complex work, requiring highly skilled scientists, high-tech microfluidics platforms and sophisticated analytical equipment, and of course the mRNA itself.
App Note / Case Study
Rapid 4D Analysis of Lipid Nanoparticle Components
Lipid nanoparticles (LNPs) have emerged as effective delivery vehicles for mRNA vaccines and nucleic acid-based drugs. Hence, the analysis of their composition, stability, and biological interactions is essential in drug development and delivery.
Product News
Particle Works Is Optimizing mRNA-LNP Formulation
Particle Works is making major contributions to the field of nanomedicine by producing automated microfluidic systems with the potential to improve efficiency in the nanotherapeutic drug development pipeline.
App Note / Case Study
Distinguishing Oxidative Impurities From Ionizable Lipids Used in LNP Formulations
Lipid nanoparticles (LNPs), comprised of ionizable lipids, are used to deliver oligonucleotides to work as therapeutics or to stimulate the immune system, as in the initial mRNA-based COVID vaccines.
Product News
MaxCyte Signs Strategic Platform License With Curamys To Enable Cell and Gene Therapies for the Treatment of Rare Intractable Diseases
Under the terms of the agreement, Curamys obtains non-exclusive clinical and commercial rights to use MaxCyte’s Flow Electroporation® technology and ExPERT™ platform.
Product News
Sartorius BIA Separations and Exopharm Sign Joint Research Agreement To Develop Integrated Technology for Large-Scale Exosome Production
Sartorius BIA Separations and Exopharm Ltd. have announced they had entered into a formal collaboration.
Product News
Particle Works Launches ALiS – An Automated and High-Throughput Platform for LNP Formulation Screening
Particle Works continues to pave the way for particle perfection with the highly anticipated launch of its second revolutionary platform, the Automated Library Synthesis (ALiS) System.
Product News
Lonza Launches New Capsule To Deliver Acid-Sensitive Active Pharmaceutical Ingredients to the Intestine
Lonza has launched an innovative new capsule solution for intestinal (enteric) drug delivery.
App Note / Case Study
Distinguishing Oxidative Impurities From Ionizable Lipids Using Electron Activated Dissociation
Lipid nanoparticles (LNPs) comprised of ionizable lipids can be used to deliver oligonucleotides to work as therapeutics or to stimulate the immune system. Detailed and sensitive characterization of the ionizable lipid and its related impurities is necessary to ensure quality, however, obtaining the level of detail needed is challenging with current LC-MS-based methodologies.
Product News
Highly Characterized, High Purity Exosome Standards
AMSBIO offer an extensive range of highly characterized, high purity exosomes for use as control standards in applications including marker assessment, immunocapture performance evaluation, exosome quantification, OMICS analysis, flow cytometry and electron microscopy.
Advertisement
